Literature DB >> 19708822

Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet.

Gerard G M D'Souza1, Volkmar Weissig.   

Abstract

The ability of a pharmacologically active molecule selectively to find its target is closely linked with its potential as a successful therapeutic drug. It has become increasingly evident that there are several pharmacologically active molecules that exert their action on molecular targets inside cell organelles. In the case of a drug molecule with no defined specificity for a particular organelle, the molecule would either need to have sufficiently long metabolic stability to allow for random interaction with the organelle to occur, or a targeting strategy for the intended subcellular compartment would need to be devised in order to potentiate therapeutic effect. In the case of molecules with a stronger affinity for a non-target subcellular compartment, there exists even greater need for the ability to control subcellular disposition. Subcellular or organelle-specific targeting has thus emerged as a new frontier in drug delivery. In this review selected examples of recent work are discussed that the authors believe might eventually lead to the application of pharmaceutical nanocarriers to create the next generation of 'magic bullets' that are capable of delivering a drug payload to a molecular target at a subcellular location.

Mesh:

Substances:

Year:  2009        PMID: 19708822     DOI: 10.1517/17425240903236101

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  13 in total

1.  The utility of an isolated mitochondrial fraction in the preparation of liposomes for the specific delivery of bioactives to mitochondria in live mammalian cells.

Authors:  Mayura A Wagle; Laura E Martinville; Gerard G M D'Souza
Journal:  Pharm Res       Date:  2011-07-15       Impact factor: 4.200

Review 2.  Bioanalysis of eukaryotic organelles.

Authors:  Chad P Satori; Michelle M Henderson; Elyse A Krautkramer; Vratislav Kostal; Mark D Distefano; Mark M Distefano; Edgar A Arriaga
Journal:  Chem Rev       Date:  2013-04-10       Impact factor: 60.622

Review 3.  Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.

Authors:  Tatiana A Slastnikova; Andrey A Rosenkranz; Michael R Zalutsky; Alexander S Sobolev
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 4.  Transduction of human recombinant proteins into mitochondria as a protein therapeutic approach for mitochondrial disorders.

Authors:  Lefkothea C Papadopoulou; Asterios S Tsiftsoglou
Journal:  Pharm Res       Date:  2011-08-27       Impact factor: 4.200

5.  Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PET.

Authors:  Cecilie B Rygh; Shengping Qin; Jai W Seo; Lisa M Mahakian; Hua Zhang; Roger Adamson; Jane Q Chen; Alexander D Borowsky; Robert D Cardiff; Rolf K Reed; Fitz-Roy E Curry; Katherine W Ferrara
Journal:  Clin Cancer Res       Date:  2010-11-24       Impact factor: 12.531

6.  Gold nanorod delivery of an ssRNA immune activator inhibits pandemic H1N1 influenza viral replication.

Authors:  Krishnan V Chakravarthy; Adela C Bonoiu; William G Davis; Priya Ranjan; Hong Ding; Rui Hu; J Bradford Bowzard; Earl J Bergey; Jacqueline M Katz; Paul R Knight; Suryaprakash Sambhara; Paras N Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-24       Impact factor: 11.205

Review 7.  Polymer-drug conjugates: origins, progress to date and future directions.

Authors:  Jindřich Kopeček
Journal:  Adv Drug Deliv Rev       Date:  2012-11-02       Impact factor: 15.470

Review 8.  Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment.

Authors:  Gantumur Battogtokh; Yong-Yeon Cho; Joo Young Lee; Hye Suk Lee; Han Chang Kang
Journal:  Front Pharmacol       Date:  2018-08-17       Impact factor: 5.810

Review 9.  Subcellular Targeting of Theranostic Radionuclides.

Authors:  Bas M Bavelaar; Boon Q Lee; Martin R Gill; Nadia Falzone; Katherine A Vallis
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.988

10.  The potential role of cell penetrating peptides in the intracellular delivery of proteins for therapy of erythroid related disorders.

Authors:  Lefkothea C Papadopoulou; Asterios S Tsiftsoglou
Journal:  Pharmaceuticals (Basel)       Date:  2013-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.